(Polski) Wywiad z prof. Jakubem Gołąbem – Program Pierwszy Polskiego Radia
Sorry, this entry is only available in Polski. ›
The latest paper of prof Jakub Golab MD, PhD on the antitumor effect of photodynamic therapy
On February 18th in European Journal of Cancer (EJC) an articleentitled 5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy has been published. The study was focused on antitumor effect of photodynamic therapy combined with 5-aza-2’-deoxycytidine, a methyltransferase inhibitor. Our observation suggest that clinically approved epigenetic agent 5-aza-2’-deoxycytidine can improve PDT induced antitumor immune response leading to […] ›
Interview regarding photodynamic therapy in the www.lekarzonkolog.pl portal [VIDEO]
Interview with prof. Jakub Gołąb regarding photodynamic therapy (PDT) in the www.lekarzonkolog.pl portal. ›
The latest paper of prof. J. Golab’s team, in Angiogenesis, prepared with the scientist form the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland and the Jagiellonian University in Krakow
In the latest issue of Angiogenesis (in print) an article of prof. Golab’s team has been published: Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis. ›
The latest paper of prof. J. Golab’s team on the mechanisms of action of photodynamic therapy (in Cell Death and Disease)
In the latest issue of Cell Death and Disease (2013, 4: e741) an article of prof. Golab team has been published: GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy. In this study prof. Golab’s team has shown for the first time that a catalytic subunit A of a bacterial subtilase cytotoxin fused to epidermal […] ›